BHRB
Burke & Herbert Financial Services Corp.
BHRB's fundamentals are mixed: revenue grew 18%, but its operating margin fell 6 points to 32%. At 12x earnings, it's trading below its usual 14x. Analysts expect earnings growth.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
BHRB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| N/A | |
| N/A |
BHRB's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BHRB.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
BHRB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 8.3x | $70.96 | — |
| Cheap | 9.9x | $59.63 | -16% |
| Current | 12x | $70.96 | — |
| Fair | 14x | $86.67 | +22% |
| Expensive | 21x | $130 | +83% |
Historical ranges are pointers, not guarantees.
BHRB's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 8.3x next year's earnings, in its cheap range.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
BHRB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for BHRB, but weaker profitability.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
BHRB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.53 | +41% |
| Q3 2026 | $6.05 | -19% |
| Q2 2026 | $6.24 | -15% |
| Q1 2026 | $7.71 | +96% |
| Q4 2025 | $7.72 | +174% |
| Q3 2025 | $7.46 | +321% |
| Q2 2025 | $7.31 | +1362% |
| Q1 2025 | $3.93 | +45% |
| Q4 2024 | $2.82 | -6.6% |
BHRB has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
BHRB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $119.7M | +40% |
| Q2 2026 | $106.9M | +23% |
| Q1 2026 | $84.7M | +2% |
| Q4 2025 | $86.5M | +4.9% |
| Q3 2025 | $85.4M | +1.9% |
| Q2 2025 | $87.1M | +26% |
| Q1 2025 | $83M | +215% |
| Q4 2024 | $82.5M | +204% |
BHRB's revenue has grown year over year for 10 quarters in a row: $120M last quarter, up 40% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | -6.1 points |
| Q2 2026 | 11% | -31 points |
| Q1 2026 | 39% | -0.3 points |
| Q4 2025 | 44% | +19 points |
| Q3 2025 | 43% | +4.2 points |
| Q2 2025 | 43% | +70 points |
| Q1 2025 | 40% | +17 points |
| Q4 2024 | 25% | +4 points |
BHRB has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
BHRB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $43.5M | +23% |
| Q2 2026 | -$1.9M | +$1.5M |
| Q1 2026 | $24.6M | -31% |
| Q4 2025 | $28.3M | -63% |
| Q3 2025 | $35.4M | +82% |
| Q2 2025 | -$3.4M | +$17M |
| Q1 2025 | $35.9M | +542% |
| Q4 2024 | $76.6M | +3203% |
BHRB has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
BHRB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.7% | +1.8M shares |
| 1 year | +34% | +5.2M shares |
| 3 years | +171% | +12.8M shares |
BHRB has 20M diluted shares, up 34% from a year ago.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has the edge over BHRB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
BHRB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.8x | High |
| Q2 2026 | 4.3x | High |
| Q1 2026 | 3.6x | Elevated |
| Q4 2025 | 3.1x | Elevated |
| Q3 2025 | 3.5x | Elevated |
| Q2 2025 | 5.3x | High |
| Q1 2025 | 4.5x | High |
| Q4 2024 | 9.3x | High |
BHRB's net debt is about 4.8 years of its operating earnings (EBITDA), up from 3.5 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BHRB.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
BHRB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.1 | Neutral |
| Stochastic | 39.2 | Neutral |
BHRB's weekly RSI is 56 (neutral) and its Stochastic is 39 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
BHRB PE vs Financial Services Sector
| Metric | BHRB | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 9.9% below |
| PE % | 33 | 63 | 30 pts below |
BHRB is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
BHRB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $70.0 | 1.3% above |
| 20 week MA | $71.0 | 0% below |
| 50 week MA | $67.3 | 5.5% above |
| 100 week MA | $63.5 | 12% above |
| 200 week MA | $62.0 | 14% above |
BHRB has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
BHRB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.4 | $43.1 | -21% |
| 2021 | $43.1 | $55.3 | +28% |
| 2022 | $55.3 | $70.8 | +28% |
| 2023 | $70.8 | $62.9 | -11% |
| 2024 | $62.9 | $62.4 | -0.7% |
| 2025 | $62.4 | $63.1 | +1% |
| 2026 YTD | $63.1 | $71.0 | +12% |
BHRB has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.